Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115054
Chunk: 483

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 483
---
 |   |
|:---------------------------------------------------------------------------------------------------------------------------------|:----|:-----------------|--------:|:--|
| Ending Balance as of December 31, 2023                                                                                           |     | $                | 104,089 |   |
| Repayment of Oramed Note                                                                                                         |     |                  | (64,200 | ) |
| Conversion into Tranche B Notes                                                                                                  |     |                  | (25,000 | ) |
| Change in fair value of Oramed Note—recorded in the consolidated statements of operations                                        |     |                  |   3,589 |   |
| Change in fair value of Oramed Note—due to instrument-specific credit risk recorded as a component of other comprehensive income |     |                  |  (6,317 | ) |
| Ending Balance as of December 31, 2024                                                                                           |     | $                |  12,161 |   |

<div align='center'>F-31</div>

Commitment Letter On June 11, 2024, the Company entered into the Commitment Letter with FSF Lender, pursuant to which FSF Lender committed to provide the Company the FSF Loan in the aggregate amount of $ 100.0million. The Commitment Amount should be payable as follows: (i) $ 85.0million no later than the Outside Date, which is 70days following the date on which the Company received the FSF Deposit and (ii) the remaining $ 15.0million within 60 days following the Initial Closing. Pursuant to the Commitment Letter, FSF Lender provided the Company a non-refundableFSF Deposit in immediately available funds in the aggregate principal amount of $ 10.0million on the Deposit Date, which amount would be creditable towards the $ 85.0million required to be funded by FSF Lender at the Initial Closing. The Company received the FSF Deposit on June 18, 2024 and issued to FSF Lender the Deposit Warrant to purchase up to an aggregate of 3,250,000shares of Common Stock (subject to adjustment for any stock dividend, stock split, reverse stock split or similar transaction), with an exercise price of $ 1.20per share. The Deposit Warrant was immediately exercisable and would expire five years from the date of issuance. If the Initial Closing did not occur on or prior to the Outside Date, the FSF Deposit should automatically convert into an unsecured